Target intelligence / Profile preview

Bacterial cytoplasmic membrane (phosphatidylglycerol-enriched)

Molecular classification
Other
01

Overview

The bacterial cytoplasmic membrane is a phospholipid bilayer that serves as the primary barrier and metabolic hub for bacterial cells. In many bacteria, particularly Gram-positive species, this membrane is heavily enriched with phosphatidylglycerol (PG), an anionic phospholipid that imparts a significant negative surface charge [1.1.5, 1.4.2]. This negative charge is a key physiological feature that allows for the selective targeting of bacteria by cationic antimicrobial peptides and lipopeptide antibiotics like daptomycin [1.1.4, 1.2.4]. Daptomycin specifically interacts with PG in a calcium-dependent manner, leading to its insertion into the membrane, oligomerization, and subsequent membrane depolarization [1.3.1, 1.3.4]. This disruption of the membrane potential and the resulting leakage of intracellular ions, such as potassium, ultimately leads to rapid bacterial cell death [1.3.3]. Beyond its role in drug interaction, the PG-enriched membrane is vital for maintaining the proton motive force required for ATP synthesis and for anchoring proteins involved in cell wall synthesis and division [1.4.3, 1.4.4]. Bacteria can develop resistance to membrane-targeting drugs by modifying PG into lysyl-phosphatidylglycerol, which reduces the net negative charge and decreases drug affinity [1.2.3, 1.2.5]. Consequently, the composition and integrity of the bacterial cytoplasmic membrane are central to both bacterial survival and the efficacy of several classes of life-saving antibiotics [1.1.1, 1.1.3].

Other names
Bacterial inner membraneAnionic bacterial membranePG-rich bacterial membraneBacterial plasma membrane
02

Mechanism of action

Antibacterial agents target the anionic phosphatidylglycerol headgroups, often requiring calcium ions for binding, which facilitates insertion into the lipid bilayer, oligomerization, and subsequent membrane depolarization or pore formation [1.1.4, 1.3.1, 1.3.4].

03

Biological functions

Cell deathOther
04

Disease associations

Infection
05

Safety considerations

Inactivation by pulmonary surfactantPotential mitochondrial membrane disruptionRisk of rhabdomyolysis (drug-specific)Development of resistance via lipid remodeling
06

Interacting drugs

Daptomycin

5 more in the full profile.

07

Biomarkers

Lysyl-phosphatidylglycerol (lysyl-PG) levelsMprF expressionPhosphatidylglycerol (PG) content

Beyond the preview

Go deeper on Bacterial cytoplasmic membrane (phosphatidylglycerol-enriched).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial cytoplasmic membrane (phosphatidylglycerol-enriched).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call